A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis

Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation

(2020) Manuel Rubio-Rivas et al.   AUTOIMMUNITY REVIEWS

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

(2019) Oliver Distler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phenotypes determined by cluster analysis and their survival in the prospective EUSTAR cohort of patients with systemic sclerosis

(2019) Vincent Sobanski et al.   Arthritis & Rheumatology

Abatacept in Early Diffuse Cutaneous Systemic Sclerosis – Results of a Phase 2 Investigator‐Initiated, Multicenter, Double‐Blind Randomized Placebo‐Controlled Trial

(2019) Dinesh Khanna et al.   Arthritis & Rheumatology

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

(2018) Keith M. Sullivan et al.   NEW ENGLAND JOURNAL OF MEDICINE

SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772)

(2018) Ganesh Raghu et al.   EUROPEAN RESPIRATORY JOURNAL

Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study

(2017) Sébastien Peytrignet et al.   RHEUMATOLOGY

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

(2016) Dinesh Khanna et al.   LANCET

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

(2016) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Role of anti-inflammatory cytokines IL-4 and IL-13 in systemic sclerosis

(2015) Xiao-Lei Huang et al.   INFLAMMATION RESEARCH

Systemic sclerosis

(2015) Yannick Allanore et al.   Nature Reviews Disease Primers

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

(2014) Jacob M. van Laar et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)

(2011) M. Herdman et al.   QUALITY OF LIFE RESEARCH

Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: Analysis of three large multicenter, double-blind, randomized controlled trials

(2009) Sogol Amjadi et al.   ARTHRITIS AND RHEUMATISM

Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument

(2009) Dinesh Khanna et al.   ARTHRITIS AND RHEUMATISM

Quality of Life in Patients with Systemic Sclerosis Compared to the General Population and Patients with Other Chronic Conditions

(2009) M. HUDSON et al.   JOURNAL OF RHEUMATOLOGY